Sanders Profiled in DCA Live About Navigating the Life and Work During the COVID-19 Pandemic
25 March 2020
DCA Live
Partner David Sanders discussed with DCA Live founder and CEO Doug Anderson how he is navigating working remotely and family life during the COVID-19 Pandemic.
Sanders said he sees several new opportunities and ventures that might be created out of the health crisis including a greater acceptance of telehealth platforms, a permanent bump for life sciences companies and a permanent increase in the use of online learning platforms and video communication platforms.
Sanders told Anderson that several things are helping him maintain morale and productivity through this crisis, including “Weekly group calls; Foley’s Daily News featuring tips on remote working and occasional comic relief regarding the current situation; calls with team members at least every other day to maintain personal contact and physical activity.”
And the one thing he is looking forward to once it’s safe to resume normal life? Playing ice hockey
DCA Live hosts events that engage the people and companies that are driving growth in the Washington, D.C. economy and counts over 12,000 business professionals as members since it was created in 2014.
The entire profile was shared on Anderson’s LinkedIn.
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."